MANNKIND CORP Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
MANNKIND CORP (MNKD) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $1.40 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2019-02-26
- MANNKIND CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2018 was $1.40M, a 250.00% increase from fiscal 2017.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2017 was $400.00K, a 33.33% decline from fiscal 2016.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2016 was $600.00K, a 88.46% decline from fiscal 2015.
- MANNKIND CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2015 was $5.20M, a 91.71% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month |
|---|---|
| 2018-12-31 | $1.40M 10-K · filed 2019-02-26 |
| 2017-12-31 | $400.00K 10-K · filed 2019-02-26 |
| 2016-12-31 | $600.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $5.20M 10-K · filed 2018-02-27 |
| 2014-12-31 | $62.70M 10-K · filed 2017-03-16 |
| 2013-12-31 | $13.90M 10-K · filed 2016-03-15 |
| 2012-12-31 | $2.90M 10-K · filed 2015-03-02 |
| 2011-12-31 | $1.70M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |